Vanguard Personalized Indexing Management’s RxSight RXST Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.2K	Buy	+12,484	New	+$75.4K	﹤0.01%	2117

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Personalized Indexing Management's RXST Position: Q2 2026 in Review

Vanguard Personalized Indexing Management opened a new position in RxSight (RXST) in Q2 2026: 12,484 shares worth $60.2K. The stake represents ﹤0.01% of the portfolio and ranks #2117 among its holdings.

151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Vanguard Personalized Indexing Management held 12,484 shares of RxSight worth $60.2K as of Q2 2026.
RxSight was a new Vanguard Personalized Indexing Management position in Q2 2026.
RxSight made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2117 holding.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.